Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

HUNTSVILLE, Ala. & ALAMEDA, Calif.–(BUSINESS WIRE)–Serina Therapeutics, Inc. (“Serina”), a privately-held, clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson’s Disease and other neurological diseases, entered into a merger agreement with AgeX Therapeutics, Inc. (NYSE American: AGE) (“AgeX”) on August 29, 2023, under which Serina will…
Click here to view original post